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REVIEW ARTICLE OPEN
Firearms-related skeletal muscle trauma: pathophysiology and
novel approaches for regeneration
Anselmo Moriscot1, Elen H. Miyabara1, Bruno Langeani 2, Antonio Belli3, Stuart Egginton 4 and T. Scott Bowen 4✉
One major cause of traumatic injury is firearm-related wounds (i.e., ballistic trauma), common in both civilian and military
populations, which is increasing in prevalence and has serious long-term health and socioeconomic consequences worldwide.
Common primary injuries of ballistic trauma include soft-tissue damage and loss, haemorrhage, bone fracture, and pain. The
majority of injuries are of musculoskeletal origin and located in the extremities, such that skeletal muscle offers a major therapeutic
target to aid recovery and return to normal daily activities. However, the underlying pathophysiology of skeletal muscle ballistic
trauma remains poorly understood, with limited evidence-based treatment options. As such, this review will address the topic of
firearm-related skeletal muscle injury and regeneration. We first introduce trauma ballistics and the immediate injury of skeletal
muscle, followed by detailed coverage of the underlying biological mechanisms involved in regulating skeletal muscle dysfunction
following injury, with a specific focus on the processes of muscle regeneration, muscle wasting and vascular impairments. Finally,
we evaluate novel approaches for minimising muscle damage and enhancing muscle regeneration after ballistic trauma, which may
have important relevance for primary care in victims of violence.
npj Regenerative Medicine            (2021) 6:17 ; https://doi.org/10.1038/s41536-021-00127-1
INTRODUCTION
Traumatic injuries have a major impact on society, contributing to
around 10% of global disease burden1. One major cause of
traumatic injuries is firearm-related wounds (i.e., ballistic trauma),
which are common occurrences in both civilian and military
populations. In addition to acute incapacity, ballistic trauma has
serious long-term health and economic consequences. For
example, in the USA the incidence of firearm injuries surpasses
100,000 per year with around 30,000 of these cases fatal, yet
clinical management and treatment of such wounds remains
suboptimal2. Furthermore in Brazil, a country with one of the
world’s highest rate of firearm-related homicides3, it has been
estimated that firearm injuries alone cost an estimated 88 million
US dollars each year, and when extended to indirect costs (e.g.,
loss to workforce, policing etc) has been estimated to be around
10 billion US dollars per year (or 0.5% of GDP)4. Alarmingly, the
prevalence of firearm injuries are reported to be increasing, even
in developed countries such as the UK and USA5. Indeed, firearm
incidents are now under more scrutiny than ever: nearly half of all
global homicides can be attributed to firearms3 while there has
been a sharp rise over recent years in lone terrorist gun attacks
across developed nations such as Canada, USA, Norway, and the
UK, which has attracted huge media attention. In fact, most violent
deaths that include use of firearms do not occur in direct conflict
zones but rather among civilians, which now accounts for 74% of
total violent deaths worldwide3. In relation to modern warfare,
such as recent direct conflicts in Afghanistan and Iraq, evidence
shows firearm wounds and explosive blasts account for almost all
of the suffered injuries6.
Following ballistic trauma, the most common primary con-
sequences include soft-tissue damage, volumetric muscle loss
(VML), haemorrhage, bone fractures, and pain7. The major site of
firearm wounds are of musculoskeletal origin in the extremities in
both military6 and civilian populations8. Indeed, injuries promoted
by firearm incidents that impact skeletal muscle induce severe
disability, extended hospitalisations, and overall a poor quality of
life9. Collectively, therefore, current evidence suggests skeletal
muscle should be a major therapeutic target following firearm-
related injuries, and improving its regeneration will promote
recovery and quality of life in afflicted patients. In this review, we
will address a global issue that has major socioeconomic impact,
with a specific focus on skeletal muscle damage and regeneration.
We will start with a brief historical perspective of the early medical
treatments developed for firearm-related wounds. After this, we
will review basic trauma ballistics and the immediate damage
they inflict on skeletal muscle, followed by what modern clinical
management procedures are in place to deal with such injuries.
We then provide an in-depth analysis of the underlying biological
mechanisms responsible for regulating skeletal muscle dysfunc-
tion following traumatic injury, including the interlinked processes
of muscle regeneration, muscle wasting and vascular impair-
ments. Finally, we discuss novel cutting-edge approaches that
may soon help alleviate muscle dysfunction and promote muscle
regeneration in even the most severely impacted patients with
firearm injuries.
HISTORICAL PERSPECTIVE
We are naturally attracted to recent advances in our own field of
research, and often miss important insights from earlier, less time-
pressured studies. As Theodor Billroth (1826–1894), a pioneering
Austrian surgeon, said ‘Only the man who is familiar with the art
and science of the past is competent to aid in its progress in the
future’. He made observations largely in accord with modern
descriptions of sprouting angiogenesis, where strands of cells arise
from existing vessels and extracellular canalisation takes place to
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form a patent lumen10. Treatment of penetrating wounds from
projectile fragments was a necessity from the earliest times,
essentially tending collateral damage of ballistic bombardment.
However, the advent of weapons targeting individuals brought
new challenges that benefitted from a more holistic approach in
patient management. The first, very brief reference to gunshot
wounds was by Billroth (1856)10, and the oldest work on surgery
with a short chapter on gunshot wounds appeared not long after
by Hieronymus Brunschwig (1497)11 It was common to illustrate
the injuries that one may have to treat by means of a stylised
figure with examples of their location and/or form. At this time,
the ‘wound man’ of the barber-surgeon takes the place of the
‘zodiac figure’ previously referred to by physicians. However, no
gunshot wounds are apparent, likely reflecting both the rarity and
lack of knowledge regarding effective treatment at that time. The
main aim was to remove poison (gunpowder residue and
battlefield contaminants) by enlarging the wound and application
of herbal poultices using warm oil to clean, adding swelling
(inflammatory) packs, followed by stimulating ointments.
Although early treatment was orientated towards binding open
wounds and allowing self-healing, advances in anatomical
knowledge gradually led to a better understanding that different
components of damaged tissue required attention. For example,
drawings by the Belgian anatomist Andreas Vesalius (1514–1564)
highlighted the similarities in arborisation of the vascular and
neural networks on a gross scale during dissection of human
cadavers, consistent with similar observations outlined by the
great Leonardo da Vinci (1452–1519).
The most significant leap in practice appears to be due to the
efforts of one man, John Hunter (1728–1792), credited with
establishing rigorous surgical practice in both Britain and
Germany. He was appointed senior surgeon for a British army
‘expedition’ to Portugal (1761), and surgeon general of the army
(1790). Based on his experience in the field, he published his
monograph ‘A treatise on the blood, inflammation and gunshot
wounds’12, the first on the subject, which was still referred to in
the clinical literature nearly a century later. His observations were
on a wide canvas, including the context that ‘Fire arms and spirits
are the first of our refinements that are adopted in uncivilised
countries’. Unusually, his attempts to improve battlefield care was
based not only on documented experience, but on experimental
observations using studies on mammals, birds, fishes and insects.
Hunter’s greatest contributions towards effective treatment
involved describing: (1) the difference between gunshot wounds
and common wounds; (2) the difference between entry and exit
wounds; (3) the effects arising from different musket ball velocity;
and (4) that ‘wound blush’ is diagnostic for closure/wound repair
(i.e., the extent of vascularisation is proportional to healing
potential—a principle re-discovered in the twentieth century
when tissue grafts became a surgical routine).
Hunter also explored the importance of vascular growth in
tissue remodelling in other ways, describing carotid artery dilation
of stags during the rutting season to sustain antler growth, and
introduced the concept that was later to be called angiogenesis in
1787 to describe the growth of blood vessels in reindeer antlers as
a result of long exposure to cold. Although often attributed to
Hunter, the term ‘angiogenesis’ was probably first used much
later13. In relation to wound healing, the role of angiogenesis was
first described by Travers (1843)14, showing that new blood
vessels grow from pre-existing vessels, later erythrocytes are seen
with oscillatory behaviour for a few hours, then a normal
circulation is established (consistent with modern intravital
microscopic observations). Further studies by the Clarks (a
husband and wife team from 1918–194015) demonstrated that a
major formative force during development was rate of flow (we
now know this to be shear stress mechanotransduction), rising
from 0 to 4mm s−1 in 30 days: differentiation was seen in vessels
with high flow, while those with low flow regressed. Subsequently,
Cliff16 and Schoefl17 used more modern experimental techniques,
combining light and electron microscopy, when studying wound
healing in skin and muscle to reveal novel structural develop-
ments. This helped lay the foundations for numerous molecular
and bioengineering studies currently exploring tissue regenerative
potential. The first successful muscle graft involved a transplanted
part of a previously denervated rat gastrocnemius, with histolo-
gical proof of survival, by Studitsky & Bosova in 196018. In 1971
Thompson published preliminary experimental and clinical results,
and a number of other papers followed from the pioneering labs
of Carlson, Gutmann, Hakelius etc. addressing diverse conditions
such as correction of facial paralysis and survival of minced muscle
tissue. With the introduction of modern infrastructure, dedicated
medical care trauma centres are now the norm across the world
for treatment and rehabilitation of firearm-related injuries19.
However, it would be wise to remember that many of our
modern clinical advances in this area were made possible by the
early courageous work of the first pioneers investigating gunshot
wounds on the battlefield.
WOUND BALLISTICS AND CLINICAL MANAGEMENT
Wound ballistics refers to the study of projectiles that penetrate
the human body with particular reference to the injury inflicted,
which can include both bullet and blast/explosive traumas20.
Impact velocities with lower limits of ~150 feet s−1 are known to
penetrate the skin to cause significant injury9. The main
mechanisms underlying penetrating ballistic tissue wounds
associated with bullets include: (1) permanent cavitation,
whereby tissue is destroyed by projectile compression and
shearing that leaves a projectile trail; and (2) temporary
cavitation, caused by tissue distention due to high-energy
pressure vibrations from the projectile’s trail (Fig. 1). Other
issues, such as localised frictional heat stress, may exacerbate
these primary insults. The extent of the firearm wound (i.e.,
depth and area damaged) is highly dependent upon projectile-
tissue characteristics, whereby both the projectile (e.g., velocity,
mass, shape, calibre, material, yawing and impact distance) and
tissue impacted (e.g., density, elasticity, and thickness) interact
to define the full extent and nature of injury21 (Fig. 1). In general,
skeletal muscle is suggested to be more sensitive to permanent
cavitation, with temporary cavitation thought to induce less
damage (unless the vasculature is disrupted) due to skeletal
muscle’s inherent elasticity21.
A common misconception is that higher projectile velocities
(e.g., >600m s−1) always induce greater wound severity compared
to low-velocity projectiles. However, extensive wounds can also be
caused by bullet fragmentation that expand wound area despite
low velocity. For example, a commonly used firearm such as the
shotgun is technically defined as low velocity, yet this device
inflicts devastating wounds when fired at close range due to high-
energy transfer21,22. Indeed, the amount of energy transferred by
the projectile is a major factor contributing to wound severity,
typically subdivided into low- or high-energy injuries. Explosive
blasts in particular, which are often suffered during military
warfare, are key examples of high-energy injuries that cause
complex muscle trauma by inflicting both superficial and deep
regional damage. Blast wounds are caused by the primary
‘explosive wave’ (which can lead to immediate air-related organ
damage and fractures; non-penetrating injuries), the secondary
‘blast wave’ (i.e., flying bomb and other fragments; penetrating
injuries), and the tertiary wave causing body displacement (i.e., the
blast wind flinging the body to cause crush injuries)23. Explosive
blasts often encapsulate the most devastating physical injuries
due to multiple effects that result in penetrating, crushing,
thermal, and infectious wounds. In regards to skeletal muscle
impacted by a projectile or blast injury, damage is inflicted via
various routes with laceration, contusion/crush injury, denervation
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(i.e., neural deficits), haemorrhage/ischaemia (i.e., vascular impedi-
ments) burns, and VML in particular of concern (Fig. 1). Both
primary firearm or blast wounds can be aggravated by secondary
trauma that further complicates severity of the injury, including
development of infection/sepsis (caused in some cases by
contamination with bullet/shotgun wadding, or other debris
collected from clothing or skin), surgical debridement of damaged
tissue (optimally performed within 6–8 h of trauma), and/or
excessive physical movement9.
The clinical management following ballistic trauma can be
generally categorised into distinct stages, including: (1) primary
care (on-site treatment and transport time); (2) secondary care
(usually hospital-based interventions); and (3) rehabilitation
(location dependent on severity) (Fig. 1). Organised trauma care
systems have been significantly strengthened worldwide over
recent decades to substantially reduce mortality rates19. One key
factor that is strongly predictive of outcome following major
trauma injuries, whether military or civilian, is the time taken to
receive medical attention24,25, underlying the ‘golden hour’ policy
mandating rapid trauma care from call to arrival. Following
primary treatment at the site of injury, patients are then rapidly
transported to organised trauma care centres (if available) for
optimised treatment, where specialist teams and equipment are
available19. Secondary care will then involve any further clinical
interventions, and in the case of ballistic trauma often include
surgical debridement and tissue reconstruction. The recovery
process then follows, where targeted rehabilitation strategies such
as physical therapy are commonly employed to aid recovery
(Fig. 1). Treatment and survival have improved with modern day
trauma care systems19, with in-hospital, 30 and 60 day mortality
rates reduced by up to 30% compared to standard care2. However,
in regards to firearm wounds we still have a poor understanding
of the underlying pathophysiological mechanisms involved and
limited strategies to help regenerate damaged muscles, thus
severely impeding rapid recovery of many patients.
PATHOPHYSIOLOGY OF SKELETAL MUSCLE TRAUMA
Given experimental (lack of suitable animal models) and ethical
(need to avoid deliberate suffering) limitations, our understanding
of the pathophysiology of skeletal muscle trauma and regenera-
tion in humans following ballistic wounds remains far from
complete, with much of our knowledge gleaned from uncon-
trolled settings involving civilian or military injuries. Indeed, most
of our mechanistic understanding related to projectile muscle
trauma and regeneration have come from indirect preclinical
trauma models rather than direct ballistic wounds. Alternative
approaches generally include muscle wounds induced by either
direct physical damage (e.g., VML, contusion, laceration, ischae-
mia, denervation, freeze) or more indirect chemical damage (i.e.,
myotoxic agents, barium chloride, irradiation)26, which have
different temporal and spatial consequences for both muscle
damage and regeneration that should be carefully considered (as
reviewed elsewhere27,28). Other approaches specific to projectile
trauma have also used soap or gelatin produced with similar
physical properties to human muscle tissue in order to investigate
properties of a projectile impact20,21. One key aspect to improving
muscle injury and regeneration after ballistic trauma is by first
understanding how the muscle immediately responds to injury or
trauma, which we will now briefly review. In particular, the ability
of the muscle to regenerate is highly dependent upon a
population of muscle-specific progenitor cells termed satellite
cells29. These are muscle stem cells juxtaposed to myofibers
sheathed under the basal lamina, which typically reside in a
quiescent state but are capable of regenerating damaged muscle
fibres upon stimuli inducing their activation29,30 (Fig. 2).
Acute response to myofiber trauma
Immediately following a muscle insult (e.g., bullet), a necrosis of
damaged myofibers occurs, which is accompanied by an increase
in intracellular calcium concentration with consequent proteo-
lysis of the damaged tissue30,31. Subsequently, key inflammatory
cells (neutrophils) are the first cells recruited to damaged tissue
Fig. 1 Summary of the key considerations involved regarding firearm-related muscle trauma and its clinical management. The properties
of the projectile (i.e., bullet or explosive blast fragments) and muscle tissue impacted interact to determine the severity of the wound, which is
dependent upon permanent and temporary cavitation as well as bullet fragmentation. The type of injury induced may range from very severe
(such as volumetric muscle loss; VML) to mild (such as a minor laceration). The speed of the clinical response and management play a hugely
important role for determining patient outcomes and functional recovery, which includes primary and secondary treatment alongside long-
term rehabilitation.
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(within 6 h after muscle injury)30,32. Next, pro-inflammatory
macrophages (also called M1 macrophages) infiltrate the
damaged tissue, which peak around 24 h after injury and are
responsible for phagocytosis and release of pro-inflammatory
cytokines such as interleukin (IL)-1 and IL-4 that promote satellite
cell proliferation31,33,34. Anti-inflammatory macrophages are
most prevalent in the injured region between 2 to 4 days post-
damage and secrete anti-inflammatory cytokines that facilitate
irreversible differentiation of satellite cell-derived myoblasts, and
thus subsequent fusion and myofibre regeneration33,34. Signal-
ling of M2 macrophages is key for triggering the permanent
differentiation of satellite cell-derived myoblasts, which fuse
(either with each other or to pre-existing myofibres) to support
muscle recovery30,35. The overall outcome is a significant necrosis
that extends beyond the limit of the projectile site itself, mainly
due to the damage of skeletal muscle fibre membrane
(sarcolemma) that is often associated with large calcium influxes
from extracellular milieu, which in turn promotes deleterious
effects on intramuscular homoeostasis. Other factors to consider
include changes to connective tissue, which have been
investigated in detail using laceration models28,36. Even relatively
small injuries in humans can affect connective tissue and induce
fibrosis, leading to scar formation, dysfunction and pain, thus
highlighting their importance31.
Acute muscle response to ballistic trauma
One major consequence for muscle viability after ballistic trauma
is the severity of mechanic-thermo injury and subsequent
myofiber trauma, which is characterised by distinct stages
including necrosis, inflammation, and muscle regeneration (Fig. 2)
(see ‘Muscle regeneration’ section). Mechano-thermo muscle
trauma is characterised by abrupt soft-tissue penetration and
heat generated by projectile friction, which is accompanied by
extensive structural disruption and atrophy of muscle fibres (see
‘Muscle wasting’ section), as well as damage to connective tissue,
the neural network, and the vascular bed (see ‘Angiogenesis’
section). Based on myotoxin/cryolesion models that inflict high
levels of sarcolemmal injury, calcium influx likely starts immedi-
ately after projectile damage and will extend up to ~30min, when
cellular mechanisms are triggered to initiate the repair process. At
this point, changes in tissue morphology in the injured area
include disrupted skeletal muscle fibres, where segmented
skeletal muscle fibres lose anchoring and shorten to appear
enlarged and dense under histological evaluation37.
A few studies have employed animal models to directly
investigate and characterise thigh muscle reaction and subse-
quent wound development following firearm bullets or steel
projectiles (~1000m s−1)38. Following gunshot injury of sheep, it
has been reported that hindlimb muscles demonstrated immedi-
ate tissue destruction and ischaemia, then at 3 days necrosis
Fig. 2 Overview of the mechanisms involved in the muscle injury-regeneration response following projectile trauma. Ballistic trauma
would induce immediate myofiber trauma, alongside secondary atrophy and vascular damage. Myofibre trauma initiates a chain of events,
including necrosis and inflammation, which then activates satellite cells to aid muscle regeneration. Satellite cells progress through a well-
established cycle of events, starting from activation and ending with fusion, which is tightly controlled by numerous transcription factors
(bottom panel; e.g., Pax7, MyoD)73. Patients that suffer mild to moderate muscle damage have a high chance of complete recovery, due to the
muscle regeneration process proceeding as normal. In contrast, patients with a severe muscle injury will show impaired recovery, due to
extensive loss of muscle tissue and impaired satellite cell function that inhibits muscle regeneration with chronic pain and fibrosis. Secondary
atrophy and vascular damage can also contribute to impaired muscle regeneration via inhibiting normal satellite cell function. Bottom panel is
adapted from Baghdadi and Tajbakhsh73.
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developed, which was complete at 6 weeks, while fibrotic scar
tissue started at 7 days39. In response to projectile missiles, early
data (in both swine and canine studies) have also shown skeletal
muscle is characterised by severe fibre swelling, a loss of muscle
architecture, sarcoplasmic clotting, and severe metabolic derange-
ment (i.e., elevated lactate and depleted high-energy phosphate
concentrations)40–42. Additional experiments in canine hindlimbs
also showed rates of protein synthesis are depressed, indicating a
rapid onset of muscle atrophy40,43. Further data confirmed that
muscle abnormalities are more severe when subjected to
haemorrhage43, with reduced blood flow and low tissue
PO2
44,45, highlighting the importance of vascular function to
maintain muscle homoeostasis and protein turnover. Collectively,
therefore, ballistic muscle injuries can be characterised by
functional loss that is underpinned by necrosis, fibrosis, fatty
infiltration, and muscle atrophy. In addition to these, vascular and
neural impediments also occur, which highlight a broad range of
potential therapeutic targets. Fortunately, many skeletal muscle
trauma injuries can be reversed, given adequate time, by
endogenous repair processes in the body that require adequate
immune, metabolic and neurovascular responses, which involve
satellite cell activation to aid muscle fibre regeneration (Fig. 2).
SKELETAL MUSCLE REGENERATION AFTER TRAUMA
The injury-repair process can be characterised by migration of
inflammatory cells to the damaged site, muscle stem cell
proliferation and differentiation, followed by maturation of
regenerating myofibers, and the restoration of extracellular matrix
components (Fig. 2). Altogether, these processes allow recovery of
muscle mass and contractile function in many instances31,46,47.
Skeletal muscle has an outstanding regenerative capacity that is
underpinned largely by a rare population of muscle-specific
progenitor cells termed satellite cells that have been shown to be
required for skeletal muscle repair48–50. Satellite cells are located
beneath the basal lamina in a mitotically quiescent state and upon
injury, such as ballistic trauma, are activated and proliferate into
myogenic precursor cells (i.e., adult myoblasts51) (Fig. 2). Subse-
quently these cells either undergo self-renewal to restore the pool
of quiescent satellite cells, or initiate a myogenic differentiation
programme by fusing with one another and/or with uninjured
portions of myofibres to re-establish the damaged areas of the
muscle tissue and the myofibre integrity, respectively52,53.
Unfortunately, at present, most of our understanding of the
muscle damage/regeneration process comes from non-ballistic
conditions, such as chemical or other physical trauma models (e.g.,
freeze injury). As such, one must be careful when extrapolating
skeletal muscle damage/regeneration from other models in
relation to ballistic trauma, in particular from those using
chemical/toxin-induced disruption where muscle regeneration
will likely follow a very different temporal and spatial
response27,28. For example, VML is commonplace after a high-
energy physical trauma where complete destruction of the local
muscle stem cell microenvironment, including the basal mem-
brane, myofiber, and vasculature is accompanied by a localised
loss of satellite cells54. In contrast, while chemical/toxic injury is
associated with less immediate physical destruction of the local
muscle stem cell environment, these can have more long-range
anatomical consequences that could induce an overall greater loss
of satellite cells vs. high-impact physical trauma54. Consequently,
the regenerative response between physical and chemical/toxic
trauma can be very different, with high-energy ballistic trauma
promoting a profound loss of local satellite cells and the myofibre
milieu that likely requires a greater migration of myogenic
progenitors to the site of injury, which may result in an ostensibly
delayed regenerative potential than that typically reported.
Mechanisms controlling satellite cell function
In addition to cytokines secreted by the inflammatory cells, several
factors produced by the damaged muscle tissue are able to
stimulate satellite cell proliferation, such as fibroblast growth
factor(FGF)-655, leukaemia inhibitory factor56, hepatocyte growth
factor (HGF)57, interleukin-658, tumour necrosis factor-α59 and
insulin-like growth factor I (IGF1)60. The myogenic programme is
regulated by key transcription factors that command the
progression from quiescence, activation, proliferation, and differ-
entiation/self-renewal of satellite cells. Quiescent satellite cells are
generally characterised by expression of the paired box 7
transcription factor (Pax7) and Myf561, that upon activation rapidly
upregulate Myf5 and start to express MyoD, which lead to the
formation of myoblasts along with intense proliferation52,62,63. As
myoblasts are formed, Pax7 expression declines and myogenin
expression marks the onset of terminal differentiation by inducing
either auto-fusion or fusion to pre-existing myofibers52,62,63. One
of the key molecules involved in myocyte fusion is the focal
adhesion kinase (FAK), a tyrosine kinase that is activated upon
binding of integrins to ligands present in the extracellular matrix.
Activated FAK associates with additional proteins that result in the
activation of other regulatory pathways such as Wnt, MAPK, Rho
guanosine triphosphatases, calcineurin, NF-kB and TGF-β64.
Ultimately, terminal differentiation is accomplished by activation
of sarcomeric and regulatory genes63, leading to re-establishment
of the structure and function of regenerating myofibers in around
3 weeks after injury35. Noteworthy, the Notch signalling pathway
has been reported as being essential in maintaining satellite cells
in the quiescent state, but is immediately downregulated upon
satellite cell activation65,66. Interestingly, recent findings now show
Notch-regulated quiescence is a highly active and orchestrated
process, which involves satellite cell secretion of extracellular
matrix collagens (via collagen V-calcitonin receptor signalling67),
as well as microRNAs (via miRNA-708-Tensin 3 axis68). In this
regard, it has been shown that quiescent satellite cells can exist in
two distinct functional states: deep quiescence (G0) or primed alert
(GAlert)
69. Satellite cells in GAlert are primed to activate and
participate in muscle repair, which can be initiated following
exposure to circulating factors such as HGF that have been
induced by anatomically distant muscle injuries70. This may have
important implications for injuries suffered after ballistic trauma
given satellite cells in GAlert have a greater regenerative capacity
69.
An important mechanism controlling the transition towards this
alert state is the kinase mTORC169, with the mTOR pathway being
described to be essential for satellite cell homoeostasis and
function during muscle regeneration since it controls the
expression of myogenic regulatory genes, such as Pax7, Myf5,
MyoD and Myogenin71. Recently, mTORC2 was also found to be
critical for satellite cell maintenance and self-renewal following
repeated injuries, supporting the various roles this kinase plays in
supporting normal muscle regeneration72. Various other molecular
regulators of satellite cell function have also been identified, as
reviewed extensively elsewhere51–53,73. However, despite skeletal
muscle regenerative process being well-defined at the structural
level, the molecular mechanisms involved are still being intensely
investigated and a better understanding of this process is crucial
for the development of more effective therapeutic strategies to
improve muscle regeneration after firearm wounds.
Muscle regeneration after mild or severe ballistic trauma
The literature is sparse in regards to the mechanisms of muscle
regeneration and satellite cell function following firearm-related
injuries. One study showed gunshot injury of sheep hindlimb
muscle documented the appearance of regenerating muscle
fibres at 7 days to aid fully recovery by 3 months39. One major
consideration for muscle regeneration following ballistic trauma is
the severity of the injury. In contrast to mild injuries (which can
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rely on endogenous repair mechanism to restore muscle function
and mass), a severe injury inflicted by ballistic trauma will include
VML and preclude full restoration of muscle mass and function,
causing chronic pain and loss of function74. Indeed, many firearm
wounds are associated with severe VML, which is characterised as
an irrecoverable injury associated with severe and permanent loss
of muscle mass and function75. This injury is associated with
limited muscle regeneration, extensive fibrosis and chronic
inflammation that accompanies loss of both intracellular contrac-
tile proteins and extracellular matrix and longstanding chronic
functional deficits76,77. VML wounds have major implications as
muscle mass cannot be restored by typical muscle regenerative
processes, which primarily involve activation of resident satellite
cells to support injury-repair and regeneration (Fig. 2). As such,
patients afflicted by severe injuries such as VML will, therefore, be
reliant on other approaches to aid muscle regeneration rather
than usual endogenous processes74 (see ‘Novel strategies to
promote muscle regeneration’ section). For example, many low-
velocity bullet and mild wounds can heal well by endogenous
mechanisms alone without any surgical intervention, resulting in
muscle regeneration, discomfort, and functional recovery (mild-
moderate injury, Fig. 2), if standard wound treatment procedures
are followed (e.g., superficial irrigation, sound cleaning, antibiotic
prophylaxis, subsequent outpatient management9). However,
when a threshold of damage occurs that overwhelms the
organism’s intrinsic capacity, chronic pain and loss of muscle
mass and impaired function become irrecoverable (e.g., severe
injury; Fig. 2). As such, when injuries are of high-energy origin and
cause severe tissue damage, aggressive operative procedures are
often used that includes early surgical debridement (to remove
devitalised tissue) as well as engraftment, where muscle flaps are
used to replace large volumes of tissue lost to aid functional
recovery. As one of the surgeon’s greatest challenges is treatment
of damaged muscle9, the development of novel strategies to
support skeletal muscle regeneration should be considered a
matter of great importance.
SKELETAL MUSCLE ATROPHY INDUCED BY TRAUMA
Mechanisms controlling muscle mass
As discussed earlier, an important consequence of ballistic trauma
is the loss of muscle mass, which is a major factor determining
functional status, quality of life and mortality78. Muscle mass is
determined by the complex balance between rates of protein
synthesis and degradation (Fig. 3), where a shift in either can
result in loss or gain of mass79. An imbalance between protein
anabolism and catabolism is often modulated by upstream factors
related to changes in hormones/growth factors, mechanical loads,
neural activation, and cellular energetic status. As such, changes
related to activity (i.e., disuse), inflammation, hyperglycaemia/
insulin resistance, intracellular calcium concentrations, or ener-
getic stress (i.e., reduced ATP/AMP ratio) are major signals that can
initiate muscle wasting following ballistic trauma (Fig. 3). On one
hand muscle wasting can result from reduced protein synthesis
due, in large part, to downregulation in one major signalling
pathway related to the insulin/IGF1-Akt-mTORC1 pathway as this
regulates protein translation80. However, wasting can also be
caused by an increased rates of protein degradation, which is
mediated by two principle systems termed the ubiquitin
proteasome and autophagy-lysosome that work alongside two
calcium-dependent pathways consisting of the calpain and
caspase proteases that are able to cleave target proteins80,81.
These atrophic systems are largely controlled by a subset of highly
regulated transcriptional factors that can induce proteolytic
activity, with the forkhead box protein O (FoxO) and NF-kB
transcription factors central80,81. These catabolic transcriptional
regulators control the gene expression of key muscle-specific E3
ligases, which repeatedly label targeted proteins with ubiquitin.
Polyubiquitinated proteins are thereafter recognised and
degraded via the 26S proteasome complex as part of the ubiquitin
proteasome system. In general, the ubiquitin proteasome system
is considered the major proteolytic pathway in the fibre
responsible for degrading sarcomeric contractile proteins82.
Therefore, E3 ligases are thought to represent a rate-limiting step
in the wasting process. Two important E3 ligases shown to be
upregulated across a wide range of wasting conditions, and key
for atrophic induction, are MAFbx and MuRF181.
The other major proteolytic system involved in wasting, which is
also regulated by FoxO transcription, is the autophagy-lysosomal
pathway. This pathway targets damaged organelles for removal,
such as the mitochondria (i.e., mitophagy), by forming autopha-
gosomes that subsequently undergo lysosomal degradation80,83.
Indeed, mitochondrial number, shape and activity is extensively
remodelled in muscles undergoing atrophy, with stimulation of
mitochondrial fission shown to induce muscle atrophy and
conversely inhibition preventing muscle mass loss83. While the
mitochondria were initially assumed to be simply energetic
organelles, recent evidence show they play a key role in regulating
important signalling molecules, which in turn, control muscle
wasting. These include reactive oxygen species (ROS), the
energetic sensor AMP protein kinase (AMPK), and the master
regulator of mitochondrial biogenesis nuclear transcriptional co-
activator peroxisome proliferator-activated receptor-gamma co-
activator-1α (PGC-1α)83 (Fig. 3). Other novel factors recently linked
to atrophy that are related to mitochondrial function and energy
homoeostasis include the fission/fusion proteins Mitofusin 2
(Mtf2)84, Drp185, and OPA186, while the family of stress-inducible
metabolic regulators sestrins have also recently been identified to
have dual effects on both anabolic (i.e., Akt-mTORC1) and
catabolic (i.e., autophagy-proteasome) control mechanisms87.
Other important hormones/growth factors secreted under cata-
bolic conditions include myostatin and glucocorticoids. Myostatin
is a member of the transforming growth factor beta (TGF-β)
superfamily and a negative regulator of muscle mass, which acts
via phosphorylated Smad2/3 to inhibit Akt signalling, as well as
inhibiting satellite cell function88. Glucocorticoids on the other
hand are steroid hormones, and despite being commonly used to
treat inflammatory conditions, they are potent mediators of
muscle wasting via activation of the glucocorticoid receptor
transcription factor, which acts to increase FoxO and MuRF1
transcription in parallel to inhibiting mTORC1 activity to suppress
protein synthesis80. Importantly, there is a close crosstalk between
anabolic and catabolic signalling pathways: for example the
protein kinase Akt can suppress atrophy via inhibiting FoxO
signalling89 (Fig. 3), although of interest a more complex interplay
between the pathways has recently come to light such that
sustained mTORC1 activation has been linked to muscle wasting
during disuse atrophy via disruption of homoeostatic autop-
hagy87. Overall, our molecular understanding of many conditions
characterised by muscle wasting (e.g., immobilisation, cancer,
heart failure, COPD, sepsis) has extensively improved over the last
few decades, showing mechanisms related to protein synthesis
are suppressed alongside rates of protein degradation being
elevated80.
Potential mechanisms of muscle wasting after ballistic trauma
Immobilisation, systemic inflammation, hyperglycaemia/insulin
resistance, and nutrient deficiency are common side effects
induced by ballistic trauma7, which are well-established mediators
of muscle wasting in both the acute and chronic setting90.
However, in regards to ballistic trauma alone, the molecular
mechanisms modulating muscle mass remain poorly explored.
Thus, most of our knowledge so far is derived from alternative
models that include chemical-thermal injury (i.e., freeze injury,
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barium chloride, notexin and cardiotoxin), physical damage (i.e.,
VML, contusion, laceration, ischaemia, eccentric physical exercise)
and chronic models mainly related to myopathies26. One major
hurdle in humans in relation to ballistic trauma is the limitations in
experimental design, while there remains a scarcity of research in
translational animal models following firearm-related muscle
injuries. Early studies utilising swine and canine traumatic models
revealed gunshot projectile damage to thigh muscle resulted in a
suppression of protein synthesis (as measured by leucine
incorporation), showing both regional and time effects40,43:
muscle protein synthesis was suppressed to the greatest extent
soon after injury and in the region closest to the site of injury.
Additional experiments in the pig hindlimb showed that
ribosomal activity (an index of protein synthesis) was also
depressed, and this was the greatest in combination with
haemorrhage43. These data reinforce the important role vascular
function plays in regulating muscle mass following trauma, while
it has been shown that projectile damage induces very low levels
of PO2
45 and blood flow44 in skeletal muscle. Collectively, while
these data support protein synthesis depression following firearm
trauma, little data have been collected in regards to changes in
proteolysis or the precise molecular regulators involved. Below, as
shown in Fig. 3, we propose a number of key mechanisms that
likely induce muscle wasting after firearm-injury which include:
1. Energetic and calcium imbalance: The energy state of the
cell (i.e., low ATP/AMP ratio) is well known to exert control
over muscle mass, via activation of the protein kinase
energy sensor AMPK, which increases FoxO signalling and
thus subsequent proteasome and autophagosome-
dependent protein degradation91 (Fig. 3). Conversely, AMPK
has also been shown to block mTORC1 activation and can
thus suppress protein synthesis as well79. Given the clear
metabolic perturbations reported to occur in skeletal
muscle following ballistic trauma (e.g., shift to anaerobic
metabolism and lower concentrations of high-energy
phosphates40–42), AMPK would likely be activated in this
setting. Another key mechanism that would likely promote
Fig. 3 Potential molecular mechanisms mediating muscle atrophy following ballistic trauma. Trauma is associated with various alterations,
such as disuse and inflammation, which can induce muscle wasting through various signalling pathways that act to elevate protein
degradation (catabolic) and suppress protein synthesis (anabolic). Two key transcription factors regulating muscle atrophy are FoxO and NF-
kb, which are activated by numerous upstream factors to promote increases in proteolysis that include the proteasome and autophagy
systems. Elevated cytosolic calcium (Ca2+) levels can also increase calpain and caspase proteolytic activation alongside impairing
mitochondrial function. See main text for expanded details.
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muscle atrophy following ballistic trauma is activation of
the key proteolytic calpain and caspase systems, which are
increased by elevated cytosolic calcium concentrations
(Fig. 3). A significant increase in cytosolic calcium flux is
common following muscle trauma and this event, which
can also induce mitochondrial dysfunction and ROS
production83, is likely a key trigger for elevating proteolytic
calpain and caspase activities to initiate cleavage of
sarcomeric proteins for subsequent degradation (e.g.,
caspase-3 targets the actomyosin complex)92. In fact, data
now show that attenuating disturbances in cytosolic
calcium (i.e., leak) under stress conditions, as observed in
conditions such as critical illness, is associated with
preserved muscle mass and function93.
2. Inflammation and hormonal disturbances: one major con-
sequence of projectile trauma is an inflammatory response,
which is increased following high-energy penetrating
wounds to the extremities and leads to a severe elevation
in systemic cytokines (i.e., IL-6, IL10, MCP-1)94. Often
infection and subsequent development of sepsis is
commonly developed in trauma, which further exacerbates
inflammation and muscle wasting95. Although there seems
to be a lack of data on firearm projectiles on skeletal muscle
atrophy related to the pro-inflammatory state, many in vitro
studies alongside in vivo patient studies during critical
illness have shown that TNF-α, IL-6, or IL1β can directly
activate the ubiquitin proteasome pathway via the tran-
scription factor NF-kb in a MuRF1-dependent manner95
(Fig. 3). While inflammatory cytokines may reduce muscle
mass, they can also induce contractile dysfunction (i.e.,
impair force generation normalised for muscle mass by
disrupting excitation-contracting coupling), which would
further exacerbate muscle weakness following ballistic
trauma. In addition glucocorticoids concentrations are
elevated under stress and could induce wasting following
ballistic trauma in a MuRF1-dependent manner in parallel
to supressing protein synthesis via downregulation of
mTORC179. Furthermore, the secreted growth and differ-
entiation factor myostatin is known to be elevated
following trauma96, which would be predicted to induce
atrophy and blunt regeneration after ballistic trauma by
means of: (1) blocking Akt activity to reduce protein
synthesis while elevating FoxO-dependent atrogene tran-
scription; and 2) blunting satellite cell proliferation and
differentiation to impede regeneration97.
3. Insulin resistance and disuse: hyperglycaemia and insulin
resistance can develop rapidly after trauma, which can
impair IGF1/insulin-Akt signalling to suppress protein
synthesis whilst in parallel activating FoxO transcription of
key atrogenes that elevate proteolysis95. Immobilisation is
often a consequence of many traumatic injuries, which
leads to severe muscle wasting. Interestingly, this is
suggested to occur via suppression of protein synthesis
alone (rather than impacting proteolysis) and be indepen-
dent of Akt signalling98. Evidence indicate that a reduction
in muscle contractions per se also drive the development of
subsequent insulin resistance, and in combination with a
systemic inflammation exacerbates insulin insensitivity to
enhance muscle wasting by both a reduction in protein
synthesis and elevation in degradation98. In addition, critical
care patients often receive drugs such as corticosteroids
and neuromuscular blocking agents that also have cata-
bolic wasting effects95.
4. Reactive oxygen species: one unifying mechanism for how
inflammation, hyperglycaemia/insulin resistance, and
immobilisation elevate muscle atrophy is via increased
levels of ROS99 (Fig. 3). Elevated ROS can directly activate
proteolysis (e.g., via redox-sensitive NF-kB transcription,
autophagy, calpain, caspase-3) and inhibit protein synthesis
(e.g., via Akt/mTORC1 blockade)99, while also damaging
intracellular proteins related to myofibrils, sarcoplasmic
reticulum-calcium handling, and energy metabolism to
induce contractile weakness and fatigue99. One major
source of ROS is the mitochondria, which is a central
mechanism driving muscle atrophy99 and this seems to be
mediated in part via a calcium leak-calpain mediated
mechanism100. Acute hypoxia is also known to be a potent
stimulus of ROS and subsequent muscle dysfunction101,
thus further highlighting the key role normal vascular
function plays in muscle homoeostasis, which we will
now discuss.
Role of angiogenesis in skeletal muscle trauma
Following ballistic trauma one major factor is haemorrhage,
however, with advances in medicine this is now often controlled
by rapid volumetric replacement that stabilises blood homo-
eostasis and pressure90. However, angiogenesis is critical not only
for wound healing but also skeletal muscle homoeostasis,
important for preventing muscle atrophy and supporting satellite
cell function (Fig. 4). The term angiogenesis refers to growth of the
smallest blood vessels, capillaries/exchange vessels, from pre-
existing vessels (cf vasculogenesis, the de novo generation of new
vessels, such as embryogenic neovascularisation); angioadaptation
describes capillary growth and regression, involving integrated
responses among vascular cells and host tissue, reflecting an
interplay between mechanical and chemical stimuli102. The
importance of capillaries cannot be understated, being essential
for substrate/O2 delivery and metabolite removal from active
tissue, as well being an essential component of the endocrine
system. There are at least 20 angiogenic growth factors that aid
stimulation of new blood vessel growth, and others that prevent
excessive growth, which help restore blood flow and enhance
oxygen diffusive exchange to ischaemic heart, limbs, and brain;
and to heal wounds103–105.
Studies suggest that many firearm wounds of the extremities
are associated with vascular trauma9, highlighting the prevalence
of direct damage. Important control mechanisms lie in endothelial
cell (EC) biology and changes with pathology (Fig. 4). Penetrating
trauma will impair blood supply, both from physiological
vasoconstriction (a powerful sympathetic drive to prevent
exsanguination) and physical disruption of the vascular network.
Widespread ischaemia will lead to tissue hypoxia, with subsequent
acute allosteric and chronic transcriptional responses orchestrated
by key regulatory hub genes such as HIF-1α and PGC-1α inducing,
among other cytokines, peptide growth factors such as vascular
endothelial growth factor (VEGF). Interestingly, it may not be the
absolute level that is important, but the link with expression of
cognate receptor(s)106. Providing anoxia is avoided, the micro-
circulation appears to be quite resilient (likely due to the high
glycolytic capacity of EC), and capable of regrowth. Delayed
recovery of O2/substrate delivery will lead to regression by
apoptosis, and rarefaction of the capillary bed in a coordinated
(non-random) manner. Tissue function has been shown to
correlate well with functional capillary density, emphasising that
angiogenesis is an appropriate therapeutic target. However, for a
short period after capillary regression remnants of the basement
membrane sleeve appear to offer a preferential channel that
aids vessel regrowth, explaining the need for rapid onset of
rehabilitation107. During recovery, the survival of any muscle graft
depends on acquiring an adequate blood supply before it dies –
the window of opportunity being inversely proportional to graft
metabolic requirements, its bulk and original vascularity.
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NOVEL STRATEGIES TO PROMOTE MUSCLE REGENERATION
AFTER BALLISTIC TRAUMA
At present the most common method for regaining muscle mass
and function following ballistic or blast injuries is, as with most
trauma injuries, via physical rehabilitation. However, we currently
lack effective therapies that can aid optimal muscle regeneration
and recovery immediately after projectile trauma. Preclinical
studies have shown that even following severe muscle loss (i.e.,
VML), treadmill running results in functional benefits108, although
optimised frequencies, durations, intensities remain poorly
explored. Interestingly, delaying the onset of an exercise regime
may provide more benefits than initiating exercise too early post-
trauma109,110 although evidence varies111. Indeed, following
projectile impact, it is important to establish a period of inactivity
to prevent further tissue impairment by contraction of the
damaged area, and aid pain control. However, as discussed
earlier, limb immobilisation can result in disuse atrophy via
suppression of protein synthesis98. Thus, the balance between
adequate rest and re-starting muscle activity must be taken into
account, and further research is required to optimise clinical
management. Another major approach for enhancing muscle
recovery after ballistic trauma includes surgical intervention, such
as muscle grafts, while standard approaches in the field include
conservative management (RICE principle; rest, ice compression
and elevation), standard medication (e.g., non-steroidal anti-
inflammatory drugs; NSAIDs), and direct muscle stimulation21.
Other approaches have also included light and acoustic waves, as
well as topical negative pressure following wound injuries7. While
these approaches may help restore some muscle mass and
function, reduce fibrosis, and activate angiogenesis following
moderate trauma, their outcome remains highly variable and
often unsuccessful in patients with the most traumatic wounds
such as VML74.
At present, we currently lack effective therapies that can aid
optimal muscle regeneration and recovery immediately after
projectile trauma. While current deployed trauma care has
reached a high level for both civilian and military human
populations, there is still a major limitation in reversing damage7.
Thus, more innovative approaches are urgently required. One area
that holds promise is that of regenerative medicine, with key
advances for treatment reported in terms of satellite cell therapy,
small-molecule therapeutics for anti-catabolic and pro-anabolic
agents, and delivery of angiogenic growth factors (Fig. 5). In
particular, it has been recently highlighted that the ability to start
regenerative treatment at a very early time point following
ballistic trauma (i.e., on the geographical location) would likely
provide the greatest step change in current trauma care, with the
risk of permanent injury during ballistic wounds suffered in
military conflict highly associated with post hoc care7.
Satellite cell therapy
Given skeletal muscle regeneration after injury is highly depen-
dent upon resident adult muscle stem cells, these form a major
putative therapeutic target after ballistic muscle wounds. Indeed,
satellite cells alongside muscle resident cells with multi-lineage
potential (such as muscle-derived stem cells, pericytes and
mesoangioblasts) and cells with non-myogenic origin (such as
mesenchymal stromal cells from bone marrow or adipose tissue
and induced pluripotent stem cells) contribute to muscle repair,
either by participating in new tissue formation or by inducing
endogenous muscle repair26,112. However, as many ballistic
wounds are associated with severe VML, muscle mass cannot be
restored by endogenous muscle regenerative processes due to
loss of the satellite cell pool. Traditional approaches for VML have,
therefore, typically included the placement of muscle flaps and
removal of scar tissue, although this has been met with limited
Fig. 4 Overview of mechanisms involved in regulating vascular function and angiogenesis. Expansion of the microcirculation may be
elicited by a number of discrete or complex stimuli, involving independent or synergistic mechanisms. These include mechanical factors
(either sensed directly by cells or indirectly via the extracellular matrix, ECM) involving initial tissue compression and haemostasis, and
subsequent muscle deformation and hyperaemia (e.g., wall strain, shear stress). Activation of resident or infiltrating mural cells (e.g.,
macrophages, mast cells), either directly due to mechanical trauma or indirectly by the following cytokine storm, may in turn activate
endothelial cells (EC). The efficacy of other cell types important for muscle regeneration, such as satellite (mesenchymal stem) cells, appears to
be related to their proximity to capillaries; perivascular pericyte communication with EC may modulate the response. Finally, chemical signals
from remote or local paracrine sources (e.g., cellular release or cleavage from ECM-binding sites) complete the repertoire required to free EC
from their usual quiescence. Figure is adapted from Egginton106.
A. Moriscot et al.
9
Published in partnership with the Australian Regenerative Medicine Institute npj Regenerative Medicine (2021)    17 
success113. As such, other advances have included autologous
minced muscle grafts (which contain essential components for
muscle regeneration)114, with one of the most promising
approaches being the transplantation of isolated satellite cells115.
Despite enthusiasm, however, various limitations during the
transplantation process have been encountered that have
conflated to yield compromised engraftment capacity, which
have included problems related to in vitro expansion, maintaining
intrinsic stemness properties, survival post-transplantation, and
limited differentiation ability and migration towards the site of
injury116. Therefore, further work needs to be done to optimise
current stem cell strategies for more efficient muscle regeneration.
Notwithstanding the aforementioned, various innovative
approaches have been proposed that include altering chemical
and physical properties of biomaterials to improve cellular
function74, thus improving biomaterial design to deliver and
retain viable cells near the damaged region and engineering a
sufficient niche26,109,117,118. Indeed, research has therefore been
focused on developing tissue engineered therapeutics that could
be used to restore muscle quantity, including the use of scaffold
and bioengineered constructs109,119 and autologous minced
muscle114. These advances in technology have allowed engi-
neered bioconstructs to be developed74, which comprise of
muscle stem cells and muscle resident cells (isolated from healthy
Fig. 5 Putative mechanistic targets and strategies for improving skeletal muscle regeneration after ballistic trauma, where volumetric
muscle loss (VML) is a common consequence. After ballistic insult (1) various time points can be targeted to enhance muscle regeneration,
which include immediately post injury (hours-days) (2), the short-term (days-weeks) (3), and the long-term (months-years) (4), with the
potential outcome being full or at least partial recovery (5). Emerging interventions/targets exploiting the intrinsic properties of both immune
and satellite cells (SCs) during the initial response phase to injury could accelerate the repair process (1). Beyond the immediate endogenous
response, short-term strategies could involve muscle and angiogenic stem cell therapies, while the administration of myofibre-targeted novel
small-molecule therapeutics could block catabolic/fibrotic activity while promoting anabolic signalling, whereas other emerging therapies
include focussing on sarcomeric mechano-dependent signalling to maintain muscle mass (2). Technological advances have allowed more
effective in vitro culturing of isolated SCs by closely recapitulating the stem cell niche and, when combined with biomaterials for transfer,
allow for a more efficient transplantation and muscle regeneration capacity although a number of technical challenges still remain (3).
Angiogenic therapies can be used to complement muscle regeneration, which stimulate vascular growth whereby a close cross-talk via local
factors between endothelial cells and SCs can enhance muscle regeneration. Long-term, electrical muscle stimulation could be incorporated
with varying frequencies to mediate myofibre plasticity and reinnervation, while physical therapy forms the mainstay of any extended
rehabilitations (4). Improvements associated with exercise training will largely be dependent upon the specific regimes employed, such as
high-intensity interval training (HIIT) or moderate-continuous training (MCT), the low- or high-resistance training exercise loads, as well as
selecting the optimal combination of exercise and nutritional supplements for maximal physiological benefits. Overall, a combined holistic
approach such as cell therapy, anti-catabolic small molecules, and physical exercise would likely provide the most effective approach for
improving muscle regeneration and aiding rapid functional recovery (5). See main text for full details of putative interventions and supporting
references.
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tissue) alongside extracellular matrix scaffold (decellularised
muscle), and implanted within injured muscle (Fig. 5). These
studies have shown benefits in animal models subjected to VML
(following removal of ~40% of the tibialis anteriormuscle, at which
point scaffold and bioconstructs were implanted, and muscle
closed). In particular, the bioconstructs resulted in de novo
myofiber formation in vivo, near normalisation of muscle mass,
and rescued strength alongside reducing fibrosis at only one-
month post injury109,119. It is important to highlight that
bioconstructs implanted with stem cells alone had limited benefit
and only when scaffolds were transplanted with both stem cells
and muscle resident cell population were the greatest effects
seen109, suggesting targeting both intra- and extracellular
components is required. In this regard, therapeutic approaches
that fully utilise the myofibre niche should be seen as essential to
fine-tune and accelerate muscle regeneration52,53, especially for
VML where large parts of the muscle milieu are lost after a ballistic
wound. For example, in vivo intravital microscopy experiments
have confirmed that ‘ghost fibre’ remnants of damaged myofibers
act as scaffolds to direct satellite cells towards the site of injury
and support muscle regeneration following cardiotoxin-induced
injury120, while another study showed that engineered ECM
scaffolds with parallel microchannels enhanced endogenous
muscle and vascular repair121. Indeed, endothelial cells are
necessary in the process to sustain satellite cell function, again
suggesting maintenance of vascular homoeostasis is critical for
the muscle regeneration process (Fig. 4). Thus, while simple
transplantation of muscle progenitor cells alone is likely beneficial,
incorporation of the satellite cell and myofibre niche seem
requisite for maximum benefit. Importantly, it has been shown
that the addition of physical exercise in combination with
constructs provides the greatest benefits, due to effects on
innervation (which constructs do not achieve)109 and potentially
on restoring Cyclin D1 to aid muscle stem cell activation122. While
implanted human stem cells have shown similar effects in mice to
restore muscle mass109, more work still needs to be done to
confirm transplantation efficiency in humans given most studies
have been performed on mice, while other problems related to
cell expansion, autologous harvesting, optimal dosage, and
viability after transplantation still need addressing26,112,123.
Although on a more encouraging note, a couple of studies using
a small number of humans with VML (n= 5–13) have confirmed
partial rescue of muscle mass and function following transplanta-
tion of acellular scaffolds derived from porcine urinary blad-
der124,125, which reinforces the potential for this biotechnology as
a treatment for humans post ballistic trauma.
Looking at other traumatic injuries (e.g., laceration or tibial
fracture model) and towards druggable targets, the anti-
hypertensive drug losartan, an angiotensin receptor inhibitor,
was able to enhance the number of regenerating fibres and
reduce fibrosis and fibre atrophy, effects enhanced in combination
with late (not immediate)-initiated physical training110,126. How-
ever, increased muscle regeneration or mass was not improved in
the non-recoverable VML experimental model post-losartan
treatment127, which highlights that unless combined with scaffold
and bioengineered constructs then the efficacy of this drug
following firearm trauma would likely be limited. Interestingly, as
the quiescent state in satellite cells represents a highly regulated
process, the opportunity to exploit this by manipulating satellite
cells towards the “primed” state (i.e., from G0 to GAlert)
70 for more
immediate activation could be utilised to aid repair70. For
example, this could be done by utilising novel drugs to prime
satellite cells that target various mechanisms, either just before
potential injury (i.e., during military battles) or immediately after,
with evidence identifying HGFA70, mTORC169, NAD+-SIRT1128
AMPKα1128, and/or FoxO signalling129 as possible targets. Alter-
native approaches could include targeting an appropriate and
rapid inflammatory response to injury, as the acute treatment with
the metabolite prostaglandin E2 (PGE2) has been shown to
improve muscle regeneration130, while improving the transition
towards an anti-inflammatory state during the injury response
process has also been shown to aid muscle regeneration via
modulation of key targets related to macrophage repair that have
included AMPK131, the myokine meteorin-like (Metrnl)132, and/or
p38 MAPK inhibitors133. Beyond this and as mentioned above the
supporting role of the stem cell niche has become a critical
consideration to aid normal muscle repair, via the direct
interaction with (or release of soluble factors from) other
neighbouring stem cell populations and the interacting extra-
cellular matrix proteins73. For example, neighbouring fibro/
adipogenic progenitors (FAPs) can release important factors that
support and enhance myogenesis during specific stages of the
repair process134, while mimicking real-world tissue stiffness (i.e.,
12kPa)135 and encapsulating the extended 3D niche environment
within implanted acellular scaffolds promotes more efficient
migration, maintenance and differentiation of stem cells136. In
addition, the development of new techniques such as intravital 3D
bioprinting has established the possibility for complex reconstruc-
tion inside tissue of living organisms that has been shown to
further aid de novo fibre formation137, while reprogramming of
other cell types (e.g., fibroblasts) towards expandable induced
muscle progenitors cells may be another option to enhance the
transplantation and regenerative process138. Overall, multiple and
exciting treatments for muscle dysfunction after ballistic trauma
are on the horizon, where in vivo treatment of injured muscle with
scaffolds and cells in combination with exercise will likely be
optimal (Fig. 5).
Inhibition of muscle atrophy via small-molecule therapeutics
At present there are no established drugs to rescue muscle
wasting in humans78, with exercise training the only proven
therapeutic treatment139. Given ballistic wounds cause immobili-
sation, metabolic dysregulation, and a systemic inflammation that
collectively trigger muscle wasting, the development of novel
in vivo drugs to hamper muscle atrophy immediately after trauma
and during rehabilitation in immobile patients would represent a
major breakthrough. This could be achieved by either attenuating
catabolic signalling and/or activating anabolic signalling mole-
cules81 (Fig. 5). In support, studies have identified a novel in vivo
small-molecule compound capable of attenuating muscle wasting
and force loss in experimental cardiac failure (induced by surgical
or toxic injury) via inhibition of the key atrophic E3 ligase
MuRF1140,141, and more recently in cancer cachexia142. High-
throughput technology screened over 100,000 compounds for
their ability to inhibit MuRF1’s interaction with the sarcomeric
protein titin, by targeting MuRF1’s central coiled-coil domain141. A
compound termed ID#704946 was shown to inhibit MuRF1 E3
ligase activity in vitro and when translated to an in vivo wasting
model following cardiac trauma, the compound inhibited skeletal
muscle MuRF1 expression, proteolysis, contractile dysfunction, and
fibre atrophy in skeletal muscle141. Exploratory proteomics and
further experiments demonstrated the novel compound normal-
ised pathways related to protein synthesis, apoptosis, and
mitochondrial function/content140,141. Thus, application of novel
in vivo MuRF1 inhibitors could offer a viable treatment of atrophy
induced by ballistic trauma injuries and further exploration is
warranted (Fig. 5). Other small-molecules worthy of further
investigation (which may aid muscle growth alongside supporting
satellite cell function) include those that inhibit myostatin, such as
small-molecule inhibitor C188-9143 or anti-myostatin antibody
(ATA 842)144, with both treatments rescuing muscle wasting
induced by chronic kidney disease and ageing. In addition, a novel
class of orally bioavailable NFκB inhibitors (termed edasalonexent
and CAT-1041) were shown to inhibit muscle wasting in both
murine and canine models of muscular dystrophy145, which could
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also be viable for trauma injuries. Another class of small molecules
termed microRNAs have also been considered as potential
therapeutic devices in skeletal muscle plasticity. Particularly
related to muscle mass control, microRNAs 29c and 208 are
involved in hypertrophy146,147. On the other hand, microRNAs 23,
27 and 486 have been implicated in attenuation of skeletal muscle
mass loss148–150. Beyond this, data have clearly shown limiting
disturbances in cytosolic calcium homoeostasis (i.e., by preventing
leak via the Ryanodine Receptor 1; RyR1) during critical illness can
prevent muscle weakness and wasting via the drug S107 via
attenuating the depletion of the subunit calstabin93.
Interestingly, rather than activation (like the proteasome
system) the other major proteolytic pathway of autophagy is
reported to be suppressed in critical illness and sepsis95. While
over-activation of autophagy can induce wasting, suppression can
also cause similar effects due to its role in maintaining protein
quality control79. Hence, medical drugs activating autophagy may
be helpful in maintaining muscle mass after ballistic trauma by
alleviating accumulation of damaged organelles or proteins such
as the mitochondria (e.g., as recently shown for sestrins87). Given
mitochondria’s key role in modulating muscle mass83, preventing
dysfunction of this organelle could represent a major therapeutic
target for rescuing muscle loss in ballistic trauma patients. In
support, recent data have shown the PGC-1α signalling axis is
disrupted in mice with VML, and that forced expression of PGC-1α
using transfection partially rescued muscle strength and oxidative
muscle function151, which reinforces previous data during disuse
atrophy152. These data highlight, for the first time, how targeting
the mitochondria may play a key role in muscle remodelling post
VML. We also know increased mitochondrial ROS production is a
key trigger for the induction of muscle wasting in various
conditions99. Emerging evidence now shows how mitochondrial-
specific antioxidants (e.g., mitoQ and SS31) can dramatically
reduce muscle impairments in various conditions such as
denervation, immobilisation, and hyperglycaemia99. For example,
a recent study showed how treatment with SS31 (a novel cell-
permeable antioxidant that locates to the mitochondria in high
concentration) could prevent acute muscle weakness induced by
sepsis in mice, which was associated with inhibition of protea-
some and calpain activation153 and further linked to a calcium
RyR1 leak-calpain mediated mechanism100. In addition, other
mitochondrial-related factors recently linked to atrophy may also
represent viable options for future manipulation, which include
Mitofusin 2 (Mtf2)84, Drp185, OPA186, and/or sestrins via their
effects on PGC-1α signalling and autophagy/mitophagy main-
tenance87. However, in relation to firearm-related muscle injuries,
little is still known regarding the effects on mitochondrial function
and ROS production but further studies are clearly warranted.
More experiments are also required to confirm the benefits of
mitochondrial antioxidants in humans following trauma or other
wasting conditions, given some studies have shown benefits in
vascular tissue154.
It has recently been highlighted that the biochemical environ-
ment during wound healing following ballistic trauma is likely key
for success7. As discussed, ROS are often increased by the elevated
circulating pro-inflammatory cytokines. Thus, some studies have
also used novel anti-inflammatory drugs to improve recovery. Key
interventions to reduce systemic inflammation in various wasting
disorders such as cancer, via targeting TNF-α using Etanercept/
Infliximab, for example, have so far been largely unsuccessful,
or even detrimental in humans trails78. Thus, further work or
alternative inhibitors are required to clarify the benefit of
suppressing these upstream targets for trauma injuries. Other
work, albeit preclinical, has shown more promise when using mild
anti-inflammatory treatments, where orally administered fish oil-
derived omega-3 poly-unsaturated fatty acids (PUFAs) in combi-
nation with high-protein supplements prevented muscle atrophy
alongside attenuating fibrosis in chemically induced muscle
wasting, suggesting this may be useful for ballistic trauma155. Of
interest, recent data have also confirmed that FAPs residing in the
muscle stem cell niche are not only crucial to support regenera-
tion but their absence leads to the onset of muscle atrophy156,
supporting FAP maintenance is key. Although seemingly they play
a double-edged role, as persistent accumulation of FAPs leads to
fibre atrophy and enhanced fibrosis during denervation via an IL-
6-Stat3 signalling axis157.
Another approach to rescuing muscle loss in ballistic trauma
could also be activating anabolic signalling molecules (Fig. 5),
which will not only stimulate muscle protein synthesis but via
crosstalk will inhibit pro-catabolic factors (e.g., FoxO). Studies have
shown conditional activation of Akt in transgenic mice induces
muscle hypertrophy without activation of satellite cells158, which
may be relevant for ballistic trauma in the event of mild injury.
However, we currently lack targeted in vivo drugs to activate Akt.
Another key node in protein synthesis is mTORC1, which can be
activated by growth factors (i.e., IGF1, insulin), nutrients (i.e.,
leucine), and mechanical load159. Data have shown oral doses of
the amino acid leucine or its metabolite β-hydroxy-
β-methylbutyrate (HMB) can increase muscle protein synthesis
via mTORC1 activation160 alongside improved muscle function
and reduced fibrosis161,162, which has been confirmed in
humans163. Thus, administration of relevant dietary supplements
to enhance mTORC1 immediately after trauma could be one
avenue to suppress catabolic effects of trauma injuries, although
more research is warranted given the surprising finding that
disuse atrophy could mediate sustained mTORC1 activation that in
turn disrupts autophagy homoeostasis to induce fibre atrophy via
inhibition of upstream sestrin signalling87. Another key mechan-
ism related to activation of mTORC1 is also the mechanism of
mechanosensing, with increased mechanical loads known to
activate mTORC1 signalling and protein synthesis by tension-
linked membrane signalling (i.e., via phosphatidic acid)159. As
such, early activation of mechanosensitive molecules could be
another avenue worthy of target, particularly as loss of mechan-
osensor integrity in muscle fibres is known to release sarcomere-
bound transcription factors related to the atrogene programme95,
while upholding of the z-disk anchored structural protein titin is
also known to be vital for sarcomere maintainence164 and linked
to control of muscle mass165 (Fig. 5). With ballistic wounds,
surgical debridement to treat firearm wounds (i.e., excision of
injured tissue) is often associated with removal of healthy tissue
and success is highly variable, which can impact muscle recovery.
Recent preclinical studies using topical bromelain treatment166,
which has selective proteolytic properties, demonstrated
improved recovery of injured muscle in the hindlimb pigs
subjected to gunshot wounds when used alongside simple
wound incision over surgical debridement. Overall encouraging
drugs have recently emerged that have anti-catabolic and pro-
anabolic effects81, however, many of these currently require rapid
translation to humans to confirm efficacy.
Angiogenic therapies
Throughout this review, we have highlighted how vascular
homoeostasis is essential for muscle regeneration and mainte-
nance of muscle mass. Angiogenic growth factors with some
specificity have already been used in clinical trials to stimulate
new blood vessel growth and restore flow to ischaemic heart,
limbs, and brain; and to heal wounds102,167,168. Angiogenic gene
therapy has been trialled as a method to deliver angiogenic
growth factors, with limited success, and current attention is
largely focussed on programmed cell therapy (Fig. 5). The list of
factors that are known to stimulate or inhibit angiogenesis is
extensive—some offer common responses to a variety of stimuli,
others are stimulus-specific, and in some cases the same factor
(such as ephrins) may have dual roles depending on stimuli
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eliciting the response—but the key player is VEGF, present in
many isoforms and acting through a range of receptor tyrosine
kinases. Therefore, an attractive option is to use cell-based therapy
as a mechanism of paracrine signalling, allowing intrinsic feedback
mechanisms to direct both the titre and mix of releasate.
Identifying the best candidate has proven difficult: only 50% of
proliferating cells at the site of angiogenic capillaries are EC, the
rest are fibroblasts; mast cells are not important in physiological
angiogenesis but degranulation is important in inflammatory
angiogenesis; greater numbers of ED1- and ED2+ ve macro-
phages are co-localised to VEGF+ ve capillaries after 2 days of
stimulation106; TIE2-expressing monocytes/macrophages regulate
revascularisation of the ischaemic limb169. However, the role of
stromal cells depends on the angiogenic stimulus: perivascular
pericytes may regress with muscle stimulation, maintain a
constant ratio with EC with hyperaemia, and increase coverage
during overload170.
There are many possible drivers of angiogenesis in addition to
chemical stimulation; increased shear stress, chronic muscle
stretch and passive exercise offer similarly potential angiothera-
pies that may prove useful in muscle regeneration171 (Fig. 5).
However, when considering the effect of rehabilitation strategies
it is important to be cautious of quick fixes, as re-establishing
haemodynamic control and effective nutrient exchange likely
requires a return to a vascular network that is close to the original
organisation and phenotype. For example, following recovery
from crush damage, muscle fibre-type grouping may accompany
reinnervation, thereby influencing recruitment pattern or fine
motor control. Apparent early success with gene therapy (using
VEGF, FGF-1 or HGF plasmids) gave transient relief from chronic
limb ischaemia in those patients who were not candidates for
conventional revascularisation procedures, but with limited
success in avoiding amputation and variable improvement in
other clinical outcomes (a plethora of collateral vessels does not
guarantee success)172. Failure to elicit adequate transformation,
even after 1 year of indirect electrical stimulation173, left muscle
inadequate for transplant purposes174, which along with devel-
opment of mechanical alternatives, led skeletal muscle as an
effective cardiac assist device to be abandoned. These observa-
tions are consistent with the concept that angiogenesis requires
overlapping, integrative responses. Chemical signals may dom-
inate in pathological angiogenesis (tumours, inflammation, wound
healing), often requiring a combination of factors to elicit an
effective response, whereas mechanical signals dominate in
physiological remodelling (ontogenetic growth, training), but
optimised rehabilitation may require a judicious combination175.
Finally, bioengineered angiogenic solutions are being
explored. Traumatic skeletal muscle injuries cause irreversible
tissue damage and impaired revascularisation, suggesting the
use of ‘engineered’ muscle transplantation may be useful176.
Currently, murine skeletal myoblasts have been co-cultured
with EC in aligned nanofibrillar scaffolds to form endothelia-
lised and aligned myotubes, showing synchronised contrac-
tility and abundant secretion of angiogenic cytokines177.
Treatment of traumatically injured muscle with endothelialised
and aligned skeletal muscle promotes the formation of highly
organised myofibers and microvasculature, along with greater
vascular perfusion, and may offer a therapeutic option when
other avenues are not feasible. To complement these
approaches, programmed cell therapy is being vigorously
pursued. Here, stem cell-based regenerative therapy is proving
to be a promising strategy for the treatment of severe muscle
diseases. Pluripotent stem cells (e.g., human iPS) may be
necessary for long-term survival of transplanted three-
dimensional (3D) engineered tissues in vivo, in order to induce
essential capillary growth into the engineered tissues after
transplantation178. In addition, satellite cell activation and their
ability to differentiate may be related to proximity to
capillaries, likely reflecting diffusion limitations. Most satellite
cells in mouse and human muscle are within 5 μm of a
capillary, and active satellite cells are located closer than
quiescent satellite cells179. Capillaries and satellite cells can
reciprocally activate each other via diffusion of secreted
growth factors (IGF, HGF, VEGF), such that a denser capillary
network is associated with a larger SC activation and
expansion106, and a more pronounced hypertrophic response
to resistance exercise180. Thus, targeting the endothelium may
be an alternative approach for enhancing satellite cells
activation and muscle regeneration following ballistic trauma,
and this should be considered a major organ to target early in
the recovery process.
FUTURE DIRECTIONS
This review has discussed some key topics related to skeletal
muscle damage and regeneration following firearm-related
wounds. While it is encouraging to see many advances in this
field that have helped improve our understanding and treatment
regarding muscle-related trauma, there are clear gaps in knowl-
edge and medical treatment that need to be addressed. After
reviewing the current literature and clinical management of
ballistic muscle injuries, we have identified a number of major
issues we believe warrant further attention, including:
● Firearm laws and access: the evidence is clear that reducing
access to firearms results in fewer injuries (both fatal and non-
fatal). Thus, preventing firearm injuries could be achieved in
many instances if access became more tightly regulated by
governments across the world (with sales of firearms
subjected to criminal background check, appropriate educa-
tional programme of firearms safety, mental health evaluation,
etc)181. Implementing educational classes highlighting the
devastating physical, social, and economical consequences of
firearms should be more common, with easier accessibility to
this from an early age as most gun-related injuries involve
young males. Setting tighter responsibilities for firearm
owners regarding safe storage can also reduce incidents,
especially accidents and suicide attempts involving children
and teenagers182.
● Improved understanding of the basic mechanisms involved in
ballistic muscle trauma: including strengthening our knowl-
edge of the underling molecular alterations is essential to
identify targets for therapeutic manipulation. This requires
development of improved translational experimental models
that better mimic ballistic trauma. Further research with
robust experimental design, and well-controlled investigations
in patients is urgently required to identify those aspects
directly impacted by firearm injuries (rather than inferring data
from indirect ballistic trauma settings, which may not translate
well). We are also in dire need of more clinical trials to confirm
the efficacy of current treatments for muscle-related firearm
injuries.
● Improved treatment strategies: by harnessing innate tissue
regenerative capacity and exogenous methods to optimise
functional recovery after injury, are feasible. To do this, we
require innovative drug discovery programmes to be
launched that will enable rapid delivery of drugs at the
geographical location of injury capable of acutely improving
muscle regeneration (i.e., in the golden hour). Based on
available evidence, early interventions that can enhance
satellite cell repair, inhibit proteolysis, and promote angiogen-
esis are key therapeutic targets. In particular, advances in the
area of engineered bioconstructs to recover muscle mass have
been encouraging124,125, and this could represent an impor-
tant treatment avenue to rescue even the most severe
firearm-related muscle injuries. More focus is also warranted
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on a multidisciplinary approach to augment muscle regenera-
tion following firearm wounds. In the long-term, more
evidence is required to optimise rehabilitation regimes,
including the most effective combination of exercise training
regimes, nutritional supplements, and drugs that will ulti-
mately aid a rapid recovery.
CONCLUSIONS
Firearm-related skeletal muscle damage and regeneration involves
an intricate balance between a variety of complex factors,
including myogenic stem cells, protein synthesis/degradation,
and angiogenesis. This review has highlighted that further
research is required to better understand the underlying
pathophysiological processes responsible for ballistic muscle
trauma and the regenerative process. However, there is currently
some exciting therapeutic approaches under development, which,
if translated to clinical practice, will likely yield faster and
improved recovery of patients plagued by firearm and blast-
related injuries.
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